CFTR mutation is associated with bone differentiation abnormalities in cystic fibrosis
Journal of Cystic Fibrosis · 2025
DOI: 10.1016/j.jcf.2025.01.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2025. Verfasst von Claire Dumortier und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Lundquist Institute, Harbor-UCLA Medical Center, Torrance 90502 CA, USA; Université de Reims Champagne-Ardenne, BIOS, Reims 51100 France. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Osteoblasts. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, Association Vaincre la Mucoviscidose, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
BACKGROUND: Cystic Fibrosis-related Bone Disease is an emerging challenge faced by 50 % of adult people with cystic fibrosis (CF). The multifactorial causes of this comorbidity remain elusive. However, congenital bone defects have been observed in animal models with CFTR mutations, suggesting its importance. The role of CFTR in bone cells development is unknown. Studies from human cells remain somewhat controversial depending on the cells used and the disease state of the patients from which the cells derived. METHODS: Therefore, we investigated the role of CFTR in osteoblast development using induced pluripotent stem cells generated from homozygous CF donors for F508del and non-CF controls. This approach allows for a clear understanding towards how the CFTR mutation may influence osteoblast differentiation independently from other confounding factors. RESULTS: We observed a lower capacity of differentiation in CF cells as compared to control, already from mesenchymal stem cells (MSC) stage, whereby they retained expression of the pluripotency marker OCT4. Furthermore, our results demonstrated a delayed osteoblast commitment and altered expression of specific markers, such as an increased RANKL/OPG ratio and decreased BMP2, suggesting a potentially perturbed bone homeostasis associated with CFTR mutation. CONCLUSIONS: This is the first study of its kind, clearly demonstrating a role for CFTR mutation in delaying osteoblast differentiation and/or regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Lundquist Institute, Harbor-UCLA Medical Center, Torrance 90502 CA, USA; Université de Reims Champagne-Ardenne, BIOS, Reims 51100 France.
- The Lundquist Institute, Harbor-UCLA Medical Center, Torrance 90502 CA, USA.
- University of Iowa, Iowa City 52242 IA, USA.
- Université de Reims Champagne-Ardenne, BIOS, Reims 51100 France.
- The Lundquist Institute, Harbor-UCLA Medical Center, Torrance 90502 CA, USA. Electronic address: denise.alalam@lundquist.org.
Förderung
- NHLBI NIH HHS
- Association Vaincre la Mucoviscidose
- National Heart, Lung, and Blood Institute
- La Région Grand Est
- Children's Hospital Los Angeles
Zitieren
APA
Dumortier, C., Frauenpreis, A., Hoarau, A., Ryan, A. L., Gangloff, S. C., Danopoulos, S., Velard, F., & Al Alam, D. (2025). CFTR mutation is associated with bone differentiation abnormalities in cystic fibrosis. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2025.01.005
Vancouver
Dumortier C, Frauenpreis A, Hoarau A, Ryan AL, Gangloff SC, Danopoulos S, et al. CFTR mutation is associated with bone differentiation abnormalities in cystic fibrosis. Journal of Cystic Fibrosis. 2025. doi:10.1016/j.jcf.2025.01.005
BibTeX
@article{Dumortier2025,
author = {Dumortier, Claire and Frauenpreis, Andrew and Hoarau, Antony and Ryan, Amy L and Gangloff, Sophie C and Danopoulos, Soula and Velard, Frédéric and Al Alam, Denise},
title = {CFTR mutation is associated with bone differentiation abnormalities in cystic fibrosis},
journal = {Journal of Cystic Fibrosis},
year = {2025},
doi = {10.1016/j.jcf.2025.01.005}
}
EUVIMED